Rankings
▼
Calendar
XNCR Q4 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$890M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$28M
-59.7% YoY
Gross Profit
$26M
90.9% margin
Operating Income
-$54M
-189.9% margin
Net Income
-$7M
-23.6% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+34.5%
Cash Flow
Operating Cash Flow
-$52M
Free Cash Flow
-$53M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$875M
Total Liabilities
$240M
Stockholders' Equity
$636M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$28M
$70M
-59.7%
Gross Profit
$26M
$70M
-63.4%
Operating Income
-$54M
$4M
-1425.1%
Net Income
-$7M
-$53M
+87.6%
Revenue Segments
Royalty
$22M
79%
Milestone
$6M
21%
← FY 2025
All Quarters